CMC Drug Product Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 38817566
Gammel Køge Landevej 283 A, 2650 Hvidovre
info@cmcdp.dk
www.cmcdp.dk
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 817.66 | 3 477.33 | 2 739.32 | 1 543.77 | 501.22 |
| Employee benefit expenses | - 439.43 | -1 065.69 | -1 881.37 | -1 391.44 | -1 349.85 |
| EBIT | 378.23 | 2 411.64 | 857.94 | 152.34 | - 848.63 |
| Other financial income | 25.50 | 54.45 | 36.74 | 0.01 | |
| Other financial expenses | -8.11 | -6.62 | -21.49 | -6.59 | -2.42 |
| Pre-tax profit | 370.12 | 2 430.52 | 890.91 | 182.49 | - 851.04 |
| Income taxes | -83.18 | - 538.52 | - 198.59 | -46.57 | 184.28 |
| Net earnings | 286.94 | 1 892.00 | 692.31 | 135.91 | - 666.76 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 5.80 | 5.80 | 5.80 | 4.48 | 4.48 |
| Investments total | 5.80 | 5.80 | 5.80 | 4.48 | 4.48 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 548.42 | 107.44 | 231.14 | ||
| Current amounts owed by group member comp. | 5.00 | 1 040.38 | 1 192.24 | 314.14 | |
| Prepayments and accrued income | 19.24 | ||||
| Current other receivables | 77.10 | 3.22 | |||
| Current deferred tax assets | 84.79 | 184.28 | |||
| Short term receivables total | 5.00 | 1 750.68 | 1 322.14 | 545.27 | 184.28 |
| Cash and bank deposits | 430.60 | 911.00 | 350.04 | 57.99 | 92.88 |
| Cash and cash equivalents | 430.60 | 911.00 | 350.04 | 57.99 | 92.88 |
| Balance sheet total (assets) | 441.40 | 2 667.48 | 1 677.98 | 607.74 | 281.64 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 0.10 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 1 301.86 | 993.65 | 267.56 | ||
| Other reserves | 39.90 | ||||
| Retained earnings | -39.90 | -1 294.82 | - 396.47 | 28.28 | 164.20 |
| Profit of the financial year | 286.94 | 1 892.00 | 692.31 | 135.91 | - 666.76 |
| Shareholders equity total | 287.04 | 1 939.04 | 1 329.50 | 471.76 | - 462.57 |
| Non-current liabilities total | |||||
| Current trade creditors | 8.50 | 24.34 | 9.94 | 2.17 | 1.23 |
| Current owed to participating | 2.06 | 1.96 | 1.96 | 1.96 | 1.96 |
| Current owed to group member | 622.01 | ||||
| Short-term deferred tax liabilities | 87.09 | 538.52 | 198.59 | 46.57 | |
| Other non-interest bearing current liabilities | 56.71 | 163.63 | 137.99 | 85.28 | 119.01 |
| Current liabilities total | 154.36 | 728.44 | 348.48 | 135.98 | 744.21 |
| Balance sheet total (liabilities) | 441.40 | 2 667.48 | 1 677.98 | 607.74 | 281.64 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.